Biotechnology - China

Filter

Current filters:

China

Popular Filters

China monoclonal antibody research forecast to increase

China monoclonal antibody research forecast to increase

28-08-2014

Several Chinese large-scale pharmaceutical enterprises have devoted themselves to research and development…

BiosimilarsBiotechnologyChinaHengrui MedicineMarkets & MarketingQilu PharmResearchShanghai Pharmaceuticals

Merck Serono starts building $105 million plant in Nantong, China

Merck Serono starts building $105 million plant in Nantong, China

27-08-2014

Merck Serono, the biotech unit of Germany’s Merck KGaA, has started construction on its new pharmaceutical…

BiotechnologyChinaMerck KGaAMerck SeronoNantongPharmaceutical manufacturing facilityProduction

HUYA to partner with Changzhou Center for Biotech Development to promote local innovation

HUYA to partner with Changzhou Center for Biotech Development to promote local innovation

18-08-2014

Chinese company HUYA Bioscience has announced a partnership with Changzhou Center for Biotech Development,…

BiotechnologyChangzhouChinaHUYA BioscienceResearch

TNI BioTech and Hubei Qianjiang link up on cancer drug development

TNI BioTech and Hubei Qianjiang link up on cancer drug development

13-08-2014

US biotech firm TNI BioTech has signed a supplemental agreement with China’s Hubei Qianjiang Pharmaceutical…

BiotechnologyBusiness FinanceChinaHubeiLicensingOncologyQianjiang PharmaceuticalResearchTNI BioTechUSA

3SBio enters patent license agreement with DiNonA for Leukotuximab

3SBio enters patent license agreement with DiNonA for Leukotuximab

08-08-2014

Chinese biotechnology company 3SBio has entered into an exclusive license with Korean DiNonA for the…

3SBioBiotechnologyChinaDiNonAKoreaLeukemiaLeukotuximabLymphocytic leukemiaManufacturingMarkets & MarketingOncology

Sinovac to provide hepatitis A vaccine in Beijing tender to 2016

Sinovac to provide hepatitis A vaccine in Beijing tender to 2016

21-07-2014

China-based Sinovac Biotech has been selected by the Beijing Health Bureau as the sole supplier of inactivated…

Anti-viralsBiotechnologyChinaHealthcareSinovac BiotechVaccination

China’s API industry is leading world production says new report

China’s API industry is leading world production says new report

05-06-2014

China’s chemical drug preparation industry and active pharmaceutical ingredient (API) industry recorded…

BiotechnologyBusiness FinanceChinaProduction

Ambrx and Zhejiang Hisun sign deal over cancer treatment

Ambrx and Zhejiang Hisun sign deal over cancer treatment

30-04-2014

USA-based clinical-stage biopharmaceutical company Ambrx and Chinese pharma firm Zhejiang Hisun Pharmaceutical…

AmbrxBiopharmaceuticalBiotechnologyBusiness FinanceChinaHealth Medical PharmaHealth Medical PharmaLicensingOncologyPharmaceutical industryUSA

WuXi PharmaTech announces Management Appointments

WuXi PharmaTech announces Management Appointments

24-04-2014

China’s WuXi PharmaTech (NYSE: WX) has announced that Dr Steve Yang has joined the company as Executive…

BiotechnologyBoardroomChinaPharmaceuticalWuXi PharmaTech

Dutch biotech Mucosis partners with Chinese firm

Dutch biotech Mucosis partners with Chinese firm

15-04-2014

Dutch biotech company Mucosis has entered into a long-term collaboration and license agreement with China-based…

BiotechnologyChangchunChief executiveChinaDiseaseHuman respiratory syncytial virusLicensingMimopath technologyNetherlandsVaccines

China Summit paves the way for Australian companies, says AusBiotech

China Summit paves the way for Australian companies, says AusBiotech

11-03-2014

Recognizing the leading role China will take globally in the future of life sciences, trade group AusBiotech…

Asia-PacificAustraliaBiotechnologyChinaManagementResearch

China set to overtake USA bioscience market

26-02-2014

Bioscience research in China is set to overtake the USA within the next five to ten years, data from…

Asia-PacificBiotechnologyChinaFinancialJapanResearchUSA

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

Walvax Biotech to take 64% stake in Genor BioPharma for around $49 million

31-12-2013

China’s Walvax Biotech has revealed it plans to acquire a controlling 64% equity stake in Shanghai’s…

Asia-PacificBiosimilarsBiotechnologyChinaMergers & AcquisitionsOncology

Merck Serono signs $232 million deal with Chinese company for BeiGene-290

Merck Serono signs $232 million deal with Chinese company for BeiGene-290

13-11-2013

Merck Serono has signed a global licensing, co-development and commercialization agreement for BeiGene-290…

Asia-PacificBeiGeneBiotechnologyChinaLicensingMerck SeronoOncology

Back to top